Amgen: Equity Report And Stock Valuation

Long Investing Ideas from Seeking Alpha

Mon, 3 Dec 2012

By Bio Vantage : Executive Summary Amgen ( AMGN ) is among the largest global biotechnology companies, with a $68B market cap and over $15.5B in combined sales in 2011. Our research shows that Amgen will have significant revenue growth from several key drugs that have been approved since 2006. As ...

Read the rest of this article on Long Investing Ideas from Seeking Alpha

Related Topics:

Related Videos

Expect More Volatility

Fri, 4 Dec 2009

Steve Romick, mananger of FPA Crescent, anticipates a volatile several years and emphasizes having a long time horizon.

Content Partners

Site Directory Site Map Our Products

Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News

International Sites: Australia Canada China France Germany Hong Kong Italy The Netherlands Norway Spain U.K. Switzerland India Finland

Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2013 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.